Suzhou, CN Breaking News Headlines Today

News about Suzhou, China

Stay current with all the latest and breaking news about Suzhou, China, compare headlines and perspectives between news sources on stories happening today. In total, 61 stories have been published about Suzhou, China which Ground News has aggregated in the past 3 months.

Local News Publishers

Suggest a source

Looking for a source we don't already have? Suggest one here.

News about Suzhou, China

News about Suzhou, China

Local News Publishers

Local News Publishers

Jaypirca® (Pirtobrutinib) Approved in China for the Treatment of Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Basecare Medical (HK.2170) Receives NMPA Approval for Core Product Geri Medium, Unlocking New Opportunities in Assisted Reproduction

ImmVira's Oncolytic Product MVR-T3011 Expanded to BCG-Naïve Bladder Cancer Patients for the First Time with Clinical Data Presented at the 2026 ASCO GU Conference

Study: Healthful Plant-Based Diet Linked to Lower Breast Cancer Risk and 28% Reduction in Mortality

A Chinese Woman Born in the 2000s Moved Into a Nursing Home, Finding It More Therapeutic than Her Workplace.

How to Book Suzhou Museum

Alphamab Oncology Announces the First Patient Dosed in a Phase III Clinical Study for Colorectal Cancer of Biparatopic HER2-targeting ADC JSKN003

Falken AZENIS FK520 Earns Highly Recommended Rating

AFC U-17 Women’s Asian Cup 2026: India drawn with Japan, Australia, Lebanon

Innovent Dosed First Participant in Phase 3 Clinical Study of IBI354 (Novel HER2 ADC) for First Line Treatment of HER2-positive Breast Cancer

Jaypirca® (Pirtobrutinib) Approved in China for the Treatment of Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Basecare Medical (HK.2170) Receives NMPA Approval for Core Product Geri Medium, Unlocking New Opportunities in Assisted Reproduction

ImmVira's Oncolytic Product MVR-T3011 Expanded to BCG-Naïve Bladder Cancer Patients for the First Time with Clinical Data Presented at the 2026 ASCO GU Conference

Study: Healthful Plant-Based Diet Linked to Lower Breast Cancer Risk and 28% Reduction in Mortality

A Chinese Woman Born in the 2000s Moved Into a Nursing Home, Finding It More Therapeutic than Her Workplace.

How to Book Suzhou Museum

Alphamab Oncology Announces the First Patient Dosed in a Phase III Clinical Study for Colorectal Cancer of Biparatopic HER2-targeting ADC JSKN003

Falken AZENIS FK520 Earns Highly Recommended Rating

AFC U-17 Women’s Asian Cup 2026: India drawn with Japan, Australia, Lebanon

Innovent Dosed First Participant in Phase 3 Clinical Study of IBI354 (Novel HER2 ADC) for First Line Treatment of HER2-positive Breast Cancer

News about Suzhou, China

News about Suzhou, China

Local News Publishers Too Big Arrow Icon

Local News Publishers Too Big Arrow Icon

Jaypirca® (Pirtobrutinib) Approved in China for the Treatment of Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Basecare Medical (HK.2170) Receives NMPA Approval for Core Product Geri Medium, Unlocking New Opportunities in Assisted Reproduction

ImmVira's Oncolytic Product MVR-T3011 Expanded to BCG-Naïve Bladder Cancer Patients for the First Time with Clinical Data Presented at the 2026 ASCO GU Conference

Study: Healthful Plant-Based Diet Linked to Lower Breast Cancer Risk and 28% Reduction in Mortality

A Chinese Woman Born in the 2000s Moved Into a Nursing Home, Finding It More Therapeutic than Her Workplace.

How to Book Suzhou Museum

Alphamab Oncology Announces the First Patient Dosed in a Phase III Clinical Study for Colorectal Cancer of Biparatopic HER2-targeting ADC JSKN003

Falken AZENIS FK520 Earns Highly Recommended Rating

AFC U-17 Women’s Asian Cup 2026: India drawn with Japan, Australia, Lebanon

Innovent Dosed First Participant in Phase 3 Clinical Study of IBI354 (Novel HER2 ADC) for First Line Treatment of HER2-positive Breast Cancer

Jaypirca® (Pirtobrutinib) Approved in China for the Treatment of Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Basecare Medical (HK.2170) Receives NMPA Approval for Core Product Geri Medium, Unlocking New Opportunities in Assisted Reproduction

ImmVira's Oncolytic Product MVR-T3011 Expanded to BCG-Naïve Bladder Cancer Patients for the First Time with Clinical Data Presented at the 2026 ASCO GU Conference

Study: Healthful Plant-Based Diet Linked to Lower Breast Cancer Risk and 28% Reduction in Mortality

A Chinese Woman Born in the 2000s Moved Into a Nursing Home, Finding It More Therapeutic than Her Workplace.

How to Book Suzhou Museum

Alphamab Oncology Announces the First Patient Dosed in a Phase III Clinical Study for Colorectal Cancer of Biparatopic HER2-targeting ADC JSKN003

Falken AZENIS FK520 Earns Highly Recommended Rating

AFC U-17 Women’s Asian Cup 2026: India drawn with Japan, Australia, Lebanon

Innovent Dosed First Participant in Phase 3 Clinical Study of IBI354 (Novel HER2 ADC) for First Line Treatment of HER2-positive Breast Cancer

Local News Publishers

Local News Publishers